Rafferty Asset Management, LLC - RAPT THERAPEUTICS INC ownership

RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 88 filers reported holding RAPT THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.25 and the average weighting 1.4%.

Quarter-by-quarter ownership
Rafferty Asset Management, LLC ownership history of RAPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,631,403
-31.5%
98,159
-22.9%
0.01%
-23.1%
Q2 2023$2,380,641
+16.4%
127,307
+14.2%
0.01%
-7.1%
Q1 2023$2,044,924
-29.3%
111,440
-23.8%
0.01%
-41.7%
Q4 2022$2,894,166
+69.0%
146,170
+105.3%
0.02%
+33.3%
Q3 2022$1,713,000
-7.0%
71,210
-15.0%
0.02%
+63.6%
Q1 2022$1,841,000
-40.4%
83,733
-0.5%
0.01%
-31.2%
Q4 2021$3,090,00084,1330.02%
Other shareholders
RAPT THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Column Group LLC 2,680,621$44,551,92129.58%
GREAT POINT PARTNERS LLC 1,458,070$24,233,1234.41%
Euclidean Capital LLC 1,315,798$21,868,5622.39%
Trustees of Columbia University in the City of New York 73,383$1,219,6252.24%
KINGDON CAPITAL MANAGEMENT, L.L.C. 805,828$13,392,8611.54%
Perceptive Advisors 1,920,658$31,921,3361.06%
Deep Track Capital, LP 1,500,000$24,930,0000.96%
Cheyne Capital Management (UK) LLP 20,000$332,4000.96%
Alphabet Inc. 540,270$8,979,2870.58%
BRAIDWELL LP 1,082,512$17,991,3490.57%
View complete list of RAPT THERAPEUTICS INC shareholders